Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases
Hierarchy View
Subtype Terms (23)
Bone Cysts
2 drugs (1 approved, 1 experimental)
Bone Diseases, Endocrine
4 drugs (3 approved, 1 experimental)
Bone Diseases, Infectious
18 drugs (16 approved, 2 experimental)
Bone Diseases, Metabolic
85 drugs (46 approved, 39 experimental)
Bone Neoplasms
41 drugs (28 approved, 13 experimental)
Bone Resorption
7 drugs (4 approved, 3 experimental)
Eosinophilic Granuloma
6 approved drugs
Osteitis Deformans
9 approved drugs
Osteoarthropathy, Primary Hypertrophic
1 experimental drug
Osteoarthropathy, Secondary Hypertrophic
Osteochondritis
1 approved drug
Osteonecrosis
23 drugs (9 approved, 14 experimental)
Spinal Diseases
57 drugs (42 approved, 15 experimental)
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (14)
Other Experimental Indicated Drugs (16)
Organization Involved with Phase 4 Indications (34)
Organization Involved with Phase 3 Indications (19)
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (19)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
